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icant increase in intake of cheese and dairy-based foods (e.g. fromage frais and
custards) but time spent outside reduced signiﬁcantly (both p < 0.001). Sun
protection behaviours differed between summer and winter only (p < 0.001).
Conclusions: The major behavioural change responsible for increased vitD
status post-study was the increase in supplement use.
Funding source(s): Clifford Craig Medical Research Trust.
LOW CALCIUM INTAKE IS RELATED TO CORTICAL POROSITY IN WOMEN
OVER 80 YEARS OF AGE
S. Iuliano 1, R. Zebaze 1, A. Ghasem-Zadeh 1, E. Seeman 1. 1Department of
Endocrinology, University of Melbourne / Austin Health, Heidelberg, Australia
E-mail: sandraib@unimelb.edu.au (S. Iuliano)
Background/Aims: About 85-90% of the skeleton in over 80 year-olds is
cortical because most trabecular bone has been resorbed. High remodel-
ling is exacerbated by secondary hyperparathyroidism likely contributed
to by low calcium intakes. We hypothesized that cortical porosity will be
high in older women and more severe in those with elevated parathyroid
hormone (PTH) and low calcium intakes.
Methods: We imaged distal tibial microstructure in 36 elderly women
(mean ± SD age 89 ± 4 years) and 73 post-menopausal women (age 60 ± 5
years) using high-resolution peripheral quantitative computed tomogra-
phy (HR-pQCT) and quantiﬁed porosity using StrAx1.0. We used t-tests for
group comparisons, and regressions to determine variable relationships.
Results: Despite similar bone area, in older compared with younger
women respectively, cortical area was ~12% smaller (101 ± 24 vs. 114 ± 17
mm2), ~21% less dense (586 ± 90 vs. 745 ± 75 mgHA/cc) and porosity ~25%
higher (60.9 ± 8.7 vs. 45.4 ± 7.4%) (all p < 0.01). In older women, PTH was
elevated (9.0 ± 4.4 vs 4.5 ± 1.8 pmol/L, p < 0.001) and dietary calcium
intake low (636 ± 175 mg/day) with 2/3 consuming <600 mg/day. PTH
levels in the elderly women were systemically elevated, and the small
sample size may have limited the ability to detect a relationship with
porosity. Dietary calcium in the elderly was related to porosity in those
with intakes below 600 mg/day (r ¼ 0.47, p ¼ 0.05).
Conclusions: We infer that a reduced calcium intake independently con-
tributes to deﬁcits in cortical bone by inﬂuencing intracortical remodel-
ling. Studies are needed to examine the effects of calcium intakes below
600 mg/day on bone loss and the effects of repletion in the elderly.
Funding source(s): Six dairy organisations from the US, Europe and
Australia.
PLASMA IRISIN LEVELS ARE INVERSELY RELATED TO INSULIN AND
HOMA-IR IN HEALTHY SUBJECTS
F. Jameel 1,2, B. Plunkett 1,2, L.G. Wood 2, M.L. Garg 1,2. 1Nutraceuticals
Research Group, University of Newcastle, Australia; 2 School of Biomedical
Sciences & Pharmacy, University of Newcastle, Australia
E-mail: Faizan.Jameel@newcastle.edu.au (F. Jameel)
Background/Aims: Irisin, a myokine encoded by ﬁbronectin type III
domain containing 5 (FNDC5) gene, expressed and produced by human
muscle and adipose tissue, has been reported to stimulate conversion of
white adipose tissue to brown adipose tissue and increase the expression
of uncoupling protein 1. Health beneﬁcial effects of exercise are thought to
be mediated via increased production of irisin. This study aimed to assess
the association between plasma irisin levels and anthropometric mea-
surements and glycaemic indices in healthy adults.
Methods: Forty nine free living healthy male and female adults were
recruited. Body weight, height, and body composition measurements
were taken. Fasting blood samples were collected for the analysis of
glucose, insulin and irisin levels. Insulin resistance score, HOMA-IR, was
calculated using fasting blood glucose and insulin values. The relationship
between plasma irisin level and anthropometric measurements, glucose,
insulin and HOMA-IR was determined using Pearson’s bivariate correla-
tion test.
Results: A signiﬁcant inverse relationship was found between plasma
irisin levels and insulin (r¼ -0.380; p ¼ 0.007) and HOMA-IR (r ¼ -0.362; p
¼ 0.011). No signiﬁcant relationship was apparent between irisin and
blood glucose level, BMI, waist/hip ratio, muscle mass or fat mass.Conclusions: This study reports an inverse relationship between plasma
irisin levels versus fasting insulin levels and HOMA-IR in healthy subjects in
support of a link between circulating levels of irisin and insulin resistance.
Funding source(s): Hunter Medical Research Institute.
ZINC INTAKE IN OBESE ADOLESCENTS AT RISK OF TYPE 2 DIABETES ON
LOW-ENERGY DIETS
M. Ho 1,2, A.L. Heath 3, L.A. Baur 1,4, C.T. Cowell 1,2,4, S. Samman 3, S.P.
Garnett 1,2,4. 1 The Children's Hospital at Westmead Clinical School,
University of Sydney, Australia; 2 Institute of Endocrinology and Diabetes,
The Children's Hospital at Westmead, Australia; 3Department of Human
Nutrition, University of Otago, New Zealand; 4Kids Research Institute, The
Children’s Hospital at Westmead, Australia
E-mail: sarah.garnett@health.nsw.gov.au (S.P. Garnett)
Background/Aims: Zinc has a critical role in metabolism, growth and
development. In adults, impaired zinc metabolism is associated with heart
disease and T2DM.This study aimed to assess zinc intake, zinc bioavail-
ability (phytate:zinc molar ratio) and the prevalence of inadequate zinc
intake in obese adolescents consuming low-energy diets differing in
macronutrient composition.
Methods: Participants were 96 obese adolescents (ages 10 to 17 years; 54
girls; mean ± SD BMI z-score 2.2 ± 0.37) with prediabetes and/or clinical
insulin resistance. Adolescents were randomised to a low-energy diet (6.0
to 8.0 MJ), which was either high carbohydrate or moderate carbohydrate
with increased protein. Zinc and phytate intakes were estimated from
three 24-hour dietary recalls at 6, 9 and 12 weeks after randomisation.
Results: Boys reported a higher absolute and energy-adjusted zinc intake
than girls, median 11.0 vs. 8.1 mg, p < 0.001, and 1.6 vs. 1.4 mg/MJ, p ¼
0.025, respectively. Zinc intake did not differ between the two diet groups
(p ¼ 0.523). However, adolescents in the high-carbohydrate group had a
higher median phytate intake than adolescents in the increased-protein
group (894 vs. 671 mg, p ¼ 0.009). The prevalence of low zinc bioavail-
ability (phytate:zinc ratio > 18) was 18% vs. 6%, p ¼ 0.113 and the preva-
lence of inadequate absorbable zinc intake, 22% vs. 13%, p ¼ 0.275.
Conclusions: Obese adolescents consuming low-energy diets are at risk of
inadequate absorbable zinc intake. Future studies should collect serum
zinc concentration data to conﬁrm the zinc status in this high risk group.
Funding source(s): Meat & Livestock Australia; Bupa Foundation Pty
Limited; Diabetes Australia Research Trust; NHF.
CUT-OFF POINTS FOR ASSOCIATIONS BETWEEN VITAMIN D AND
MUSCULOSKELETAL OUTCOMES VARY IN WOMEN AGED 36e57 YEARS
F. Wu 1, K. Wills 1, L. Laslett 1, B. Oldenburg 2, M. Seibel 3, G. Jones 1, T.
Winzenberg 1. 1Menzies Research Institute Tasmania, University of
Tasmania, Hobart, TAS, Australia; 2 School of Public Health and Preventive
Medicine, Monash University, Australia; 3Bone Research Program, ANZAC
Research Institute, The University of Sydney, Australia
E-mail: Feitong.Wu@utas.edu.au (F. Wu)
Background/Aims: To describe associations between serum 25-hydrox-
yvitamin D [25(OH)D] and musculoskeletal outcomes in middle-aged
women.
Methods: This cross-sectional analysis from a cohort of 348 women (mean
age 50 year) used nonlinear least-squares estimation to determine ﬂexion
points for associations of 25(OH)D with lumbar spine (LS) bone mineral
density (BMD), femoral neck (FN) BMD, lower limb muscle strength (LMS),
timed up and go test (TUG), functional reach test (FRT), lateral reach test
(LRT) and step test (ST) and piecewise regression to determine how as-
sociations differed by 25(OH)D level.
Results: Mean (95%CI) ﬂexion points were 25 (16, 33), 42 (16, 68), 26 (20,
32), 41 (23, 60), 18 (12, 24), 48 (-158, 254) and 24 (12, 35) nmol/L for FN
BMD, LS BMD, TUG, ST, FRT, LRT and LMS, respectively. Signiﬁcant associ-
ations between 25(OH)D and musculoskeletal outcomes occurred only in
participants with low 25(OH)D. Differences in slope between 25(OH)D
groups became statistically signiﬁcant at 35 nmol/L for FN BMD, blow (in
low group)¼ 0.0044 (95%CI: 0.0009, 0.0078), between-group difference in
b (Db) ¼ 0.0044, p ¼ 0.020; and TUG, blow¼-0.027 (-0.052, -0.002); Db ¼
-0.030, p¼ 0.028; 30 nmol/L for LS BMD, blow¼ 0.0059 (0.0002, 0.0117); Db
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0.697, p¼ 0.027 and LMS, blow¼ 1.703 (0.241, 3.165); Db¼ 1.802, p¼ 0.020,
and 60 nmol/L for ST, blow ¼ 0.030 (-0.001, 0.061); Db ¼ 0.051, p ¼ 0.038.
Conclusions: In middle-aged women, the point at which relationships be-
tween 25(OH)D and musculoskeletal outcomes change varies for different
outcomes. The current cut-off of 50 nmol/L appears too high for some out-
comesbut reasonableoverall to optimiseboneandbalance in thispopulation.
Funding source(s): NHMRC and RACGP / Osteoporosis Australia Bone
Health Research Grant.
GLYCATED ALBUMIN: SAMPLE STABILITY OF AN EMERGING GLYCAEMIC
CONTROL BIOMARKER
A.N. Reynolds 1, B.J. Venn 1, J.I. Mann 1,2. 1Department of Human Nutrition,
University of Otago, New Zealand; 2Department of Medicine, University of
Otago, New Zealand
E-mail: Andrew.Reynolds@otago.ac.nz (A.N. Reynolds)
Background/Aims: Glycated albumin (GA) is an emerging biomarker of
glycaemic control reﬂecting glycaemia in the previous two weeks. It is the
ratio of glycated to total albumin expressed as a percentage. It is stable to
day-to-day ﬂuctuations in glycaemia; independent of plasma volume or
albumin concentration; and unaffected by haemodialysis or haemglobi-
nopathies. Used clinically in India and China, GA correlates with HbA1c
and fasting glucose. Validation of sample stability is required.
Methods: Three experiments were undertaken using plasma samples of
people with type 2 diabetes. 1. Short-term stability of 15 samples under-
going freeze-thaw cycles. 2. Short-term stability of 15 samples stored at 4
oC for up to two days. 3. Long-term stability of 25 samples assayed 5 years
ago and subsequently stored at -80 oC.
Results: The mean GA of fresh samples and those undergoing 1, 2, 5 and 10
freeze-thaw cycles were 18.15, 18.14, 18.08, 18.14, and 18.19%, respectively
e values did not differ from baseline (p ¼ 0.86). The mean GA of thawed
samples stored at 4 oC for 12, 24 and 48 h were 17.36, 17.33, 17.37 and 17.61,
respectively e the 48 h sample differed from baseline (p ¼ 0.009). The
mean GAof samples stored at -80 oC for 5 years (34.99%) was double that of
the fresh samples (18.89%).
Conclusions: GA appears stable to multiple short-term freeze thaw cycles
and to storage at 4 oC for up to 24 h. Long-term storage resulted in an
appreciable increase in GA. Further work is required to characterise the
stability of GA under various storage conditions.
Funding source(s): New Zealand Artiﬁcial Limb Board.
SELENIUM OR VITAMIN E MITIGATES HYPERTHERMIA IN GROWING
PIGS
F. Liu 1, J.J. Cottrell 1, B.J. Leury 1, S. Chauhan 1, P. Celi 1,2, A. Abrasaldo 1, F.R.
Dunshea 1. 1 Faculty of Veterinary & Agricultural Sciences, The University of
Melbourne, Australia; 2 Faculty of Veterinary Science, The University of
Sydney, Australia
E-mail: fanliu@student.unimelb.edu.au (F. Liu)
Background/Aims: An increasing prevalence of heat waves presents the
challenge of managing hyperthermia, particularly in intensively farmed
animals. Therefore the aim of this experiment was to quantify protective
effects of anti-oxidants selenium (Se) or vitamin E (VE) during hyper-
thermia in growing pigs.
Methods: Thirty-six gilts (Large White  Landrace, 28 ± 4 kg) were fed
control (0.24 ppm Se, 17 IU/kg VE), Se (1.0 ppm Se yeast, 17 IU/kg VE), or VE
(0.24 ppm Se, 200 IU/kg VE) 80% restricted for 14 days, then exposed to
thermoneutral (TN) vs. cyclic hyperthermia (HT) for seven days (20 C vs.
35 C 0900-1700h/28 C). Hyperthermia was assessed by skin and rectal
temperature (ST and RT), respiration rate (RR), heart rate (HR) and blood
bicarbonate. Data were analysed using restricted maximum likelihood for
the effects and interactions of diet, temperature, time.
Results: As expected with restricted feeding, feed intake was not affected,
so effects could be ascribed to HTor antioxidants rather than to differences
in feed intake. Despite similar feed intakes, HT increased body weight (p <
0.001). HT increased ST and RT (p < 0.001), and both were mitigated by Se
(p ¼ 0.019 and < 0.001). RR increased during HT (p < 0.001) which was
ameliorated by Se, but elevated with VE (p ¼ 0.006). HT reduced HR at1600h, which was mitigated by Se and VE (p < 0.001). Also, VE protected
reductions in blood bicarbonate during HT (p ¼ 0.016).
Conclusions: Short term Se or VE supplementation ameliorated the effects
of hyperthermia in growing pigs.
Funding source(s): Australian Pork Limited, Department of Agriculture,
Fisheries and Forestry.
META-ANALYSIS OF RCTS REPORTING ON THE CORONARY HEART
DISEASE RISK OF CALCIUM SUPPLEMENTATION WITH OR WITHOUT
VITAMIN D
J.R. Lewis 1,2, S. Radvelli-Bagatini 2, R.L. Prentice 3, L. Mosekilde 4, J.M.
Lappe 5, J.M. Simpson 6, J.S. Chen 7, L. Rejenmark 4, R.L. Prince 2. 1 Sir
Charles Gairdner Hospital, Australia; 2University of Western Australia,
Australia; 3 Fred Hutchinson Cancer Research Center, Seattle, USA; 4Aarhus
University Hospital, Denmark; 5Creighton University, USA; 6 School of
Public Health, University of Sydney, Australia; 7 Institute of Bone and Joint
Research, University of Sydney, Australia
E-mail: richard.prince@uwa.edu.au (R.L. Prince)
Background/Aims: Recent single centre papers suggest that calcium
supplementation increases the risk of coronary heart disease. These risks
were re-evaluated by a consortium who undertook a meta-analysis of all
randomised controlled trials of calcium supplements with or without
vitamin D for coronary heart disease events and all-cause mortality.
Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, and
EMBASE databases were searched from January 1966 to May 2013 for
randomised controlled trials of calcium supplementation with or without
vitaminD inwomen aged over 50 yearswith event data fromhospitalisation
veriﬁed by clinical review or hospital record and/or death certiﬁcate data.
Results: Of 661 potentially eligible studies, 18 met the inclusion criteria,
reporting data from 63,564 participants with 3,390 coronary heart disease
events and 4,157 deaths. Coronary heart disease hospitalisation or death
events pooled RR for calcium of 1.02 (95% CI: 0.96, 1.09; p¼ 0.51). All-cause
mortality data (17 trials) had an RR for calcium of 0.96 (95%CI: 0.91, 1.02; p
¼ 0.18). Heterogeneity among the trials was low for both primary out-
comes (I2¼ 0%). Secondary outcomes RR for myocardial infarction, chronic
coronary heart disease and angina pectoris and acute coronary syndrome
were 1.08 (95%CI: 0.92,1.26; p¼ 0.33), 0.92 (95%CI: 0.73,1.15; p¼ 0.46) and
1.09 (95%CI: 0.95, 1.24; p ¼ 0.22) respectively.
Conclusions: Calcium supplementation with or without vitamin D does
not increase coronary heart disease or all-cause mortality risk in women
consuming calcium to prevent fractures.
Funding source(s): Raine Medical Research Foundation Priming Grant.
SUITABILITYOF VITAMIN D SUPPLEMENTS TO IMPROVE PSYCHOLOGICAL
WELLBEING OVERWINTER
M. Polak 1, T. Conner 1, J. Haszard 2, A. Reeder 3, M. Harper 2, L.
Houghton 2. 1Department of Psychology, University of Otago, Dunedin,
New Zealand; 2Department of Human Nutrition, University of Otago,
Dunedin, New Zealand; 3Department of Preventive and Social Medicine,
University of Otago, Dunedin, New Zealand
E-mail: mariapolak@psy.otago.ac.nz (M. Polak)
Background/Aims: Vitamin D has been associated with psychological
wellbeing in previous studies, for example depression, anxiety, and sea-
sonal affective disorder. We tested whether vitamin D supplementation
over winter is beneﬁcial for psychological wellbeing in healthy women.
Methods: One hundred and ﬁfty two healthy women (18-40 years of age)
in Dunedin, New Zealand (S46) have been randomly assigned to receive
six monthly doses of 50,000 IU of oral vitamin D3 or placebo. They
completed the Centre for Epidemiologic Studies Depression Scale (CES-D),
the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS),
and the Flourishing Scale (FS) every month. Additionally, they reported on
positive and negative moods every twomonths for three consecutive days.
Participants provided a blood sample for 25-hydroxyvitamin D analysis at
the beginning and at the end of the study. Differences for each wellbeing
measure between the groups were analysed using ANCOVA, controlling for
confounders and baseline values. Mixed model regression was used to test
the treatment by time interaction effect.
